EUVIMEDEUVIMED entdecken
LeserbriefKommentarOpen Access · CC BY-NC 4.0

Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis

Man Sun, Dan Zang, Jun Chen

European Respiratory Journal · 2026-03 · 67 (3) · 2502148

DOI: 10.1183/13993003.02148-2025 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Respiratory Journal, online erschienen am 19.03.2026. Verfasst von Man Sun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Hospital of Dalian Medical University, Dalian City, China. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Oncology, The Second Hospital of Dalian Medical University, Dalian City, China.
  • These authors contributed equally to this work.
  • Department of Oncology, The Second Hospital of Dalian Medical University, Dalian City, China chenjun_dmu@126.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Sun, M., Zang, D., & Chen, J. (2026). Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis. European Respiratory Journal, 67(3), 2502148. https://doi.org/10.1183/13993003.02148-2025

Vancouver

Sun M, Zang D, Chen J. Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis. European Respiratory Journal. 2026;67(3):2502148. doi:10.1183/13993003.02148-2025

BibTeX
@article{Sun2026,
  author = {Sun, Man and Zang, Dan and Chen, Jun},
  title = {Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis},
  journal = {European Respiratory Journal},
  year = {2026},
  volume = {67},
  number = {3},
  pages = {2502148},
  doi = {10.1183/13993003.02148-2025}
}
Kostenlos starten →